---
title: "Plus Therapeutics unit CNSide signs national coverage deal with Elevance Health for CSF cancer assay"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290823784.md"
description: "Plus Therapeutics signed a national coverage agreement with Elevance Health for its CNSide CSF cancer assay, effective May 1, 2026. This deal covers approximately 45.4 million people in the US, bringing total contracted coverage to 126 million. The test has demonstrated high accuracy with 92% sensitivity and 95% specificity across over 11,000 volumes since 2020."
datetime: "2026-06-25T11:30:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290823784.md)
  - [en](https://longbridge.com/en/news/290823784.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290823784.md)
---

# Plus Therapeutics unit CNSide signs national coverage deal with Elevance Health for CSF cancer assay

-   Plus Therapeutics signed a national coverage agreement with Elevance Health for the CNSide cerebrospinal fluid tumor cell enumeration assay, effective May 1, 2026. \* Agreement covers about 45.4 million people in the US; total contracted coverage for the assay rises to 126 million. \* CNSide test volumes exceed 11,000 since 2020 across more than 120 US cancer institutions, with 92% sensitivity, 95% specificity. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606250730PRIMZONEFULLFEED9752367) on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PSTV.US](https://longbridge.com/en/quote/PSTV.US.md)
- [ELV.US](https://longbridge.com/en/quote/ELV.US.md)

## Related News & Research

- [Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey | ELV Stock News](https://longbridge.com/en/news/294391678.md)
- [Elevance Health, Inc. $ELV Shares Acquired by Cetera Investment Advisers](https://longbridge.com/en/news/293896171.md)
- [How Mixed Q2 Earnings and Higher EPS Guidance Will Impact Elevance Health (ELV) Investors](https://longbridge.com/en/news/294124186.md)
- [Elevance Health, Inc. $ELV Shares Acquired by Sei Investments Co.](https://longbridge.com/en/news/293841088.md)
- [Bessemer Group Inc. Has $1.26 Million Holdings in Elevance Health, Inc. $ELV](https://longbridge.com/en/news/293717109.md)